primary antibodies for gcs Search Results


antibodies against nrf2  (Proteintech)
96
Proteintech antibodies against nrf2
Antibodies Against Nrf2, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+for+gcs/GCLC+Antibody/pm40015625-216-8-11
Average 96 stars, based on 1 article reviews
antibodies against nrf2 - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier
antibodies for gucy1a3  (Proteintech)
93
Proteintech antibodies for gucy1a3
FIGURE 5 Role of NO/sGC in regulating the baseline tone of placental and non-placental vessels. On the baseline of vessel tone, SNP mediated dilation in several species (A—human: normal placental vessels (CPV, n = 25) and umbilical vessels (CUV, n = 25); B—sheep: placental vessels (SPV, n = 16), umbilical vessels (SUV, n = 11), and fetal sheep mesenteric arteries (SMA, n = 4), C–rat: umbilical vessels and mesenteric arteries) with or without ODQ. Bay 41-2272 induced dilation in CPV (n = 12) and CUV (n = 5) (A). The protein expressions of <t>GUCY1A3,</t> GUCY1B3, cGMP, and PRKG1 in placental vessels and umbilical vessels were shown (D). The real-time recording images were also shown. *P <0.05; ***P <0.001; ****P <0.0001; ###P <0.001; ####P <0.0001.
Antibodies For Gucy1a3, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+for+gcs/GUCY1A3+Antibody/pm37293496-107-2-5
Average 93 stars, based on 1 article reviews
antibodies for gucy1a3 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
anti gclm antibody  (Proteintech)
94
Proteintech anti gclm antibody
FIGURE 5 Role of NO/sGC in regulating the baseline tone of placental and non-placental vessels. On the baseline of vessel tone, SNP mediated dilation in several species (A—human: normal placental vessels (CPV, n = 25) and umbilical vessels (CUV, n = 25); B—sheep: placental vessels (SPV, n = 16), umbilical vessels (SUV, n = 11), and fetal sheep mesenteric arteries (SMA, n = 4), C–rat: umbilical vessels and mesenteric arteries) with or without ODQ. Bay 41-2272 induced dilation in CPV (n = 12) and CUV (n = 5) (A). The protein expressions of <t>GUCY1A3,</t> GUCY1B3, cGMP, and PRKG1 in placental vessels and umbilical vessels were shown (D). The real-time recording images were also shown. *P <0.05; ***P <0.001; ****P <0.0001; ###P <0.001; ####P <0.0001.
Anti Gclm Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+for+gcs/GCLM+Antibody/pmc13015032-318-5-8
Average 94 stars, based on 1 article reviews
anti gclm antibody - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
antibodies against gclc  (ABclonal Biotechnology)
95
ABclonal Biotechnology antibodies against gclc
Figure 3. Effect of arsenite on astrocyte GCL mRNA and protein expression. Primary cortical astrocytes (n = 3 from 3 separate dissections) were treated with 10 µg/mL ActD (+ActD; gray bars) or its vehicle (−ActD; blue bars) for 30 min, after which NaAsO2 was spiked into experimental wells to a final concentration of 15µM. Four hours later, RNA was isolated, and (A) <t>GCLC</t> and <t>(D)</t> <t>GCLM</t> mRNA expression was determined by RT-qPCR. Data are expressed as mean + SEM fold change over untreated cells (−NaAsO2, −ActD; =1). Exact p-values are shown for each pairwise comparison determined by two-way ANOVA followed by Fisher’s uncorrected LSD test for multiple comparisons. Protein expression of (B) GCLC and (E) GCLM was assessed by Western blotting, as described in the Section 4. Exact p-values are shown for each pairwise comparison determined to be significant by a paired t-test. Representative blots for (C) GCLC and (F) GCLM are shown.
Antibodies Against Gclc, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+for+gcs/GCLC+Rabbit+pAb/pm40508184-221-29-36
Average 95 stars, based on 1 article reviews
antibodies against gclc - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
rabbit polyclonal antitgfb1i1  (Proteintech)
93
Proteintech rabbit polyclonal antitgfb1i1
Figure 3. Effect of arsenite on astrocyte GCL mRNA and protein expression. Primary cortical astrocytes (n = 3 from 3 separate dissections) were treated with 10 µg/mL ActD (+ActD; gray bars) or its vehicle (−ActD; blue bars) for 30 min, after which NaAsO2 was spiked into experimental wells to a final concentration of 15µM. Four hours later, RNA was isolated, and (A) <t>GCLC</t> and <t>(D)</t> <t>GCLM</t> mRNA expression was determined by RT-qPCR. Data are expressed as mean + SEM fold change over untreated cells (−NaAsO2, −ActD; =1). Exact p-values are shown for each pairwise comparison determined by two-way ANOVA followed by Fisher’s uncorrected LSD test for multiple comparisons. Protein expression of (B) GCLC and (E) GCLM was assessed by Western blotting, as described in the Section 4. Exact p-values are shown for each pairwise comparison determined to be significant by a paired t-test. Representative blots for (C) GCLC and (F) GCLM are shown.
Rabbit Polyclonal Antitgfb1i1, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+for+gcs/UGCG+Antibody/pm37423913-75-21-24
Average 93 stars, based on 1 article reviews
rabbit polyclonal antitgfb1i1 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
primary antibodies against gclc  (Boster Bio)
92
Boster Bio primary antibodies against gclc
Figure 3. Effect of arsenite on astrocyte GCL mRNA and protein expression. Primary cortical astrocytes (n = 3 from 3 separate dissections) were treated with 10 µg/mL ActD (+ActD; gray bars) or its vehicle (−ActD; blue bars) for 30 min, after which NaAsO2 was spiked into experimental wells to a final concentration of 15µM. Four hours later, RNA was isolated, and (A) <t>GCLC</t> and <t>(D)</t> <t>GCLM</t> mRNA expression was determined by RT-qPCR. Data are expressed as mean + SEM fold change over untreated cells (−NaAsO2, −ActD; =1). Exact p-values are shown for each pairwise comparison determined by two-way ANOVA followed by Fisher’s uncorrected LSD test for multiple comparisons. Protein expression of (B) GCLC and (E) GCLM was assessed by Western blotting, as described in the Section 4. Exact p-values are shown for each pairwise comparison determined to be significant by a paired t-test. Representative blots for (C) GCLC and (F) GCLM are shown.
Primary Antibodies Against Gclc, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+for+gcs/Anti-GCLC+Antibody+Picoband/pmc07370281-181-5-10
Average 92 stars, based on 1 article reviews
primary antibodies against gclc - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier
primary antibodies for gcs  (Novus Biologicals)
90
Novus Biologicals primary antibodies for gcs
Figure 3. Effect of arsenite on astrocyte GCL mRNA and protein expression. Primary cortical astrocytes (n = 3 from 3 separate dissections) were treated with 10 µg/mL ActD (+ActD; gray bars) or its vehicle (−ActD; blue bars) for 30 min, after which NaAsO2 was spiked into experimental wells to a final concentration of 15µM. Four hours later, RNA was isolated, and (A) <t>GCLC</t> and <t>(D)</t> <t>GCLM</t> mRNA expression was determined by RT-qPCR. Data are expressed as mean + SEM fold change over untreated cells (−NaAsO2, −ActD; =1). Exact p-values are shown for each pairwise comparison determined by two-way ANOVA followed by Fisher’s uncorrected LSD test for multiple comparisons. Protein expression of (B) GCLC and (E) GCLM was assessed by Western blotting, as described in the Section 4. Exact p-values are shown for each pairwise comparison determined to be significant by a paired t-test. Representative blots for (C) GCLC and (F) GCLM are shown.
Primary Antibodies For Gcs, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+for+gcs/Goblet+Cells+Antibody+(FIS+3G12%2F3)+%5BHRP%5D/10__26650_slash_experimed__2021__974943-81-0-5
Average 90 stars, based on 1 article reviews
primary antibodies for gcs - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
antibodies against sgcα  (Santa Cruz Biotechnology)
93
Santa Cruz Biotechnology antibodies against sgcα
Figure 3. Effect of arsenite on astrocyte GCL mRNA and protein expression. Primary cortical astrocytes (n = 3 from 3 separate dissections) were treated with 10 µg/mL ActD (+ActD; gray bars) or its vehicle (−ActD; blue bars) for 30 min, after which NaAsO2 was spiked into experimental wells to a final concentration of 15µM. Four hours later, RNA was isolated, and (A) <t>GCLC</t> and <t>(D)</t> <t>GCLM</t> mRNA expression was determined by RT-qPCR. Data are expressed as mean + SEM fold change over untreated cells (−NaAsO2, −ActD; =1). Exact p-values are shown for each pairwise comparison determined by two-way ANOVA followed by Fisher’s uncorrected LSD test for multiple comparisons. Protein expression of (B) GCLC and (E) GCLM was assessed by Western blotting, as described in the Section 4. Exact p-values are shown for each pairwise comparison determined to be significant by a paired t-test. Representative blots for (C) GCLC and (F) GCLM are shown.
Antibodies Against Sgcα, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+for+gcs/GCS-%CE%B1-1+Antibody/pm29604271-90-26-30
Average 93 stars, based on 1 article reviews
antibodies against sgcα - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
anti-gcsam  (Atlas Antibodies)
N/A
germinal center-associated, signaling and motility, Recombinant Protein Epitope Signature Tag (PrEST) antigen sequence
   Buy from Supplier
anti-gcs-beta-2 antibody  (Boster Bio)
N/A
Boster Bio Anti-GCS-beta-2 Antibody (Catalog# A13667). Tested in IHC-P, IF (paraffin), ELISA applications. This antibody reacts with Human, Mouse, Rat.
   Buy from Supplier
anti-hmgcs1 antibody picoband  (Boster Bio)
N/A
Boster Bio Anti-HMGCS1 Antibody Picoband® catalog # A05313-2. Tested in ELISA, Flow Cytometry, IF, IHC, ICC, WB applications. This antibody reacts with Human. The brand Picoband indicates this is a premium antibody that guarantees superior
   Buy from Supplier
anti-hmgcs1 (full length) polyclonal antibody  (Creative BioMart)
N/A
Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.http://www.creative-diagnostics.com/Anti-Human-HMGCS1-Antibody-28925-147.htm
   Buy from Supplier

Image Search Results


FIGURE 5 Role of NO/sGC in regulating the baseline tone of placental and non-placental vessels. On the baseline of vessel tone, SNP mediated dilation in several species (A—human: normal placental vessels (CPV, n = 25) and umbilical vessels (CUV, n = 25); B—sheep: placental vessels (SPV, n = 16), umbilical vessels (SUV, n = 11), and fetal sheep mesenteric arteries (SMA, n = 4), C–rat: umbilical vessels and mesenteric arteries) with or without ODQ. Bay 41-2272 induced dilation in CPV (n = 12) and CUV (n = 5) (A). The protein expressions of GUCY1A3, GUCY1B3, cGMP, and PRKG1 in placental vessels and umbilical vessels were shown (D). The real-time recording images were also shown. *P <0.05; ***P <0.001; ****P <0.0001; ###P <0.001; ####P <0.0001.

Journal: Frontiers in endocrinology

Article Title: Specific dilation pattern in placental circulation and the NO/sGC role in preeclampsia placental vessels.

doi: 10.3389/fendo.2023.1182636

Figure Lengend Snippet: FIGURE 5 Role of NO/sGC in regulating the baseline tone of placental and non-placental vessels. On the baseline of vessel tone, SNP mediated dilation in several species (A—human: normal placental vessels (CPV, n = 25) and umbilical vessels (CUV, n = 25); B—sheep: placental vessels (SPV, n = 16), umbilical vessels (SUV, n = 11), and fetal sheep mesenteric arteries (SMA, n = 4), C–rat: umbilical vessels and mesenteric arteries) with or without ODQ. Bay 41-2272 induced dilation in CPV (n = 12) and CUV (n = 5) (A). The protein expressions of GUCY1A3, GUCY1B3, cGMP, and PRKG1 in placental vessels and umbilical vessels were shown (D). The real-time recording images were also shown. *P <0.05; ***P <0.001; ****P <0.0001; ###P <0.001; ####P <0.0001.

Article Snippet: The primary antibodies for GUCY1A3 (Proteintech, Cat#12605-1-AP), GUCY1B3 (Proteintech, Cat#19011-1-AP), and PRKG1 (Proteintech, Cat#21646-1-AP) were incubated overnight at 4°C.

Techniques:

FIGURE 6 Dilation in placental vessels in normal and preeclamptic pregnancy and related mechanisms. The concentrations of NO in placental vessels and umbilical plasma from both groups were shown (A). The mRNA and protein expressions of eNOS as well as the phosphorylated eNOS are shown (A). On the 5HT-induced vasoconstriction platform, concentration-dependent SNPs, or Bay 41-2272 induced dilation responses in placental vessels from both groups (B). On the baseline of vessel tone, SNP caused dilation in the presence or absence of ODQ (C). Bay 41-2272 decreased the baseline of placental vessel tone (C). The sGC activity and protein expressions of GUCY1A3, GUCY1B3, and PRKG1 were shown (D). *P <0.05; **P <0.01; ***P <0.001; ****P <0.0001; ####P <0.0001.

Journal: Frontiers in endocrinology

Article Title: Specific dilation pattern in placental circulation and the NO/sGC role in preeclampsia placental vessels.

doi: 10.3389/fendo.2023.1182636

Figure Lengend Snippet: FIGURE 6 Dilation in placental vessels in normal and preeclamptic pregnancy and related mechanisms. The concentrations of NO in placental vessels and umbilical plasma from both groups were shown (A). The mRNA and protein expressions of eNOS as well as the phosphorylated eNOS are shown (A). On the 5HT-induced vasoconstriction platform, concentration-dependent SNPs, or Bay 41-2272 induced dilation responses in placental vessels from both groups (B). On the baseline of vessel tone, SNP caused dilation in the presence or absence of ODQ (C). Bay 41-2272 decreased the baseline of placental vessel tone (C). The sGC activity and protein expressions of GUCY1A3, GUCY1B3, and PRKG1 were shown (D). *P <0.05; **P <0.01; ***P <0.001; ****P <0.0001; ####P <0.0001.

Article Snippet: The primary antibodies for GUCY1A3 (Proteintech, Cat#12605-1-AP), GUCY1B3 (Proteintech, Cat#19011-1-AP), and PRKG1 (Proteintech, Cat#21646-1-AP) were incubated overnight at 4°C.

Techniques: Clinical Proteomics, Concentration Assay, Activity Assay

Figure 3. Effect of arsenite on astrocyte GCL mRNA and protein expression. Primary cortical astrocytes (n = 3 from 3 separate dissections) were treated with 10 µg/mL ActD (+ActD; gray bars) or its vehicle (−ActD; blue bars) for 30 min, after which NaAsO2 was spiked into experimental wells to a final concentration of 15µM. Four hours later, RNA was isolated, and (A) GCLC and (D) GCLM mRNA expression was determined by RT-qPCR. Data are expressed as mean + SEM fold change over untreated cells (−NaAsO2, −ActD; =1). Exact p-values are shown for each pairwise comparison determined by two-way ANOVA followed by Fisher’s uncorrected LSD test for multiple comparisons. Protein expression of (B) GCLC and (E) GCLM was assessed by Western blotting, as described in the Section 4. Exact p-values are shown for each pairwise comparison determined to be significant by a paired t-test. Representative blots for (C) GCLC and (F) GCLM are shown.

Journal: International journal of molecular sciences

Article Title: Arsenite-Mediated Transcriptional Regulation of Glutathione Synthesis in Mammalian Primary Cortical Astrocytes.

doi: 10.3390/ijms26115375

Figure Lengend Snippet: Figure 3. Effect of arsenite on astrocyte GCL mRNA and protein expression. Primary cortical astrocytes (n = 3 from 3 separate dissections) were treated with 10 µg/mL ActD (+ActD; gray bars) or its vehicle (−ActD; blue bars) for 30 min, after which NaAsO2 was spiked into experimental wells to a final concentration of 15µM. Four hours later, RNA was isolated, and (A) GCLC and (D) GCLM mRNA expression was determined by RT-qPCR. Data are expressed as mean + SEM fold change over untreated cells (−NaAsO2, −ActD; =1). Exact p-values are shown for each pairwise comparison determined by two-way ANOVA followed by Fisher’s uncorrected LSD test for multiple comparisons. Protein expression of (B) GCLC and (E) GCLM was assessed by Western blotting, as described in the Section 4. Exact p-values are shown for each pairwise comparison determined to be significant by a paired t-test. Representative blots for (C) GCLC and (F) GCLM are shown.

Article Snippet: After destaining, membranes were blocked in Odyssey blocking buffer (LI-COR Environmental, Lincoln, NE, USA) for 1 h at room temperature, followed by overnight incubation at 4 ◦C with primary antibodies against GCLc (0.93 ug/mL; rabbit polyclonal; ABclonal Technology, Woburn, MA, USA), GCLM (0.38 ug/mL; rabbit polyclonal; ABclonal), and GS (0.51 ug/mL; mouse monoclonal; Novus Biologicals, Centennial, CO, USA).

Techniques: Expressing, Concentration Assay, Isolation, Quantitative RT-PCR, Comparison, Western Blot